Researchers asked whether there are any signs or symptoms that predict later diagnosable bipolar disorder with reasonable accuracy. If so, this would be useful for prognosis and preparation, but even more importantly, encourage efforts targeting prevention.
Here: highlights of a new study of the antipsychotic agent ziprasidone in bipolar spectrum disorder -- and a quick synopsis of another trial of a recently approved inhaled form of the antipsychotic loxapine in bipolar disorder and schizophrenia.
Ranked by the World Health Organization among the top 10 most disabling disorders in the world, bipolar disorder was the subject of review in a recent study. Here, a video summary by the lead author of a study on bipolar disorder and aggression.
The psychiatrist’s role is to act as a consultant to maximize the likelihood of a successful taper and discontinuation and to minimize collateral morbidities or withdrawal complications. This slideshow features common scenarios in which a planned discontinuation of psychotropic medications occurs.
The bipolar diagnosis introduces some unique aspects to violence prevention and management, although the general principles are similar to those for patients with other psychiatric disorders. More in this slideshow.
Evidence suggests that co-occurrence with ADHD is a marker of preadolescent-onset mania. This slideshow provides some evidence for you to decide whether this form of very early-onset mania represents a developmental subtype of the disorder.